BE644613A - - Google Patents

Info

Publication number
BE644613A
BE644613A BE644613A BE644613A BE644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A
Authority
BE
Belgium
Prior art keywords
emi
penetration
composition
solution
dimethyl
Prior art date
Application number
BE644613A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE644613A publication Critical patent/BE644613A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE644613A 1963-12-09 1964-03-02 BE644613A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32915163A 1963-12-09 1963-12-09

Publications (1)

Publication Number Publication Date
BE644613A true BE644613A (xx) 1964-07-01

Family

ID=23284077

Family Applications (1)

Application Number Title Priority Date Filing Date
BE644613A BE644613A (xx) 1963-12-09 1964-03-02

Country Status (2)

Country Link
BE (1) BE644613A (xx)
CA (1) CA1005761A (xx)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527863A (en) * 1964-11-25 1970-09-08 Brunswick Corp Tissue infiltrant
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3548057A (en) * 1969-04-29 1970-12-15 Merck & Co Inc Topical administration of vitamin b12
US3548052A (en) * 1964-10-27 1970-12-15 Canada Packers Ltd Heparin compositions and methods of using same
FR2182935A1 (xx) * 1972-04-05 1973-12-14 Procter & Gamble

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3548052A (en) * 1964-10-27 1970-12-15 Canada Packers Ltd Heparin compositions and methods of using same
US3527863A (en) * 1964-11-25 1970-09-08 Brunswick Corp Tissue infiltrant
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3548057A (en) * 1969-04-29 1970-12-15 Merck & Co Inc Topical administration of vitamin b12
FR2182935A1 (xx) * 1972-04-05 1973-12-14 Procter & Gamble

Also Published As

Publication number Publication date
CA1005761A (en) 1977-02-22

Similar Documents

Publication Publication Date Title
DE69434121T2 (de) Pharmazeutische zusammensetzung zur immunverstärkenden therapie
Ford et al. Pityrosporum folliculitis and ketoconazole
Bayer et al. Inhibitory Effect of Ethanol on Canine Exocrine Pancreatk Secretion
EP1283708A2 (fr) Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
BE644613A (xx)
CA2080820C (fr) Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations
Wolinsky Chemotherapy and pathology of experimental photochromogenic mycobacterial infections
Buzia¹ et al. Antibacterial action of certain tretinoin and benzoyl peroxide liposomes. Case study
US4801444A (en) Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis
Molin et al. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group
Cusini et al. Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome
US3737552A (en) Method of treating gonorrhea
Murray et al. Disseminated histoplasmosis following long-term steroid therapy for reticulosarcoma
CN103561735B (zh) 具有抗菌、抗溃疡和免疫调节作用的药物制剂
JPH06239757A (ja) 抗アレルギー剤
De Koning et al. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
CH675684A5 (xx)
JPH0587048B2 (xx)
Pentland et al. Failure of ejaculation with indoramin.
EP1317922A1 (fr) Preparation antipyretique renfermant du xylitol
JP2004099613A (ja) 自己免疫疾患治療用ガノデルマルシダム胞子
Pesigan et al. Pararosaniline pamoate (CI-403-A) in the treatment of Schistosoma japonicum infection in the Philippines
AHONEN et al. Ketoconazole is Effective against the Chronic Mucocutaneous Candidosis of Autoimmune Polyendocrinopathy‐Candidosis‐Ectodermal Dystrophy (APECED)
KOLMER Bismuth arsphenamine sulphonate (bismarsen) in the treatment of syphilis and of other spirochetic infections
RU2362554C2 (ru) Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства